Johnson Matthey PLC (LON:JMAT – Get Free Report) has been assigned an average rating of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is GBX 2,218.33.
JMAT has been the subject of several recent analyst reports. UBS Group reiterated a “neutral” rating and set a GBX 2,200 price target on shares of Johnson Matthey in a research note on Friday. Deutsche Bank Aktiengesellschaft boosted their target price on Johnson Matthey from GBX 1,922 to GBX 2,120 and gave the stock a “buy” rating in a report on Tuesday, April 7th. Finally, Berenberg Bank lowered their price target on Johnson Matthey from GBX 2,250 to GBX 2,100 and set a “buy” rating on the stock in a report on Monday, March 23rd.
Check Out Our Latest Stock Report on JMAT
Insider Buying and Selling
Johnson Matthey Stock Up 2.7%
Johnson Matthey stock traded up GBX 58 during mid-day trading on Friday, hitting GBX 2,188. 172,920 shares of the company’s stock were exchanged, compared to its average volume of 2,911,408. Johnson Matthey has a 1-year low of GBX 1,660 and a 1-year high of GBX 2,434. The stock has a 50 day moving average of GBX 2,000.77 and a two-hundred day moving average of GBX 2,105.43. The company has a current ratio of 1.65, a quick ratio of 0.76 and a debt-to-equity ratio of 71.01. The stock has a market cap of £3.67 billion, a P/E ratio of -33.20, a P/E/G ratio of 49,242.50 and a beta of 0.91.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Read More
- Five stocks we like better than Johnson Matthey
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
- Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
